Socioeconomic status and in-hospital outcomes for patients undergoing heart transplantation or ventricular assist device implantation.


Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
11 2023
Historique:
revised: 19 06 2023
received: 02 05 2023
accepted: 25 07 2023
medline: 13 11 2023
pubmed: 7 8 2023
entrez: 7 8 2023
Statut: ppublish

Résumé

Although lower socioeconomic status (SES) has been associated with worse in-hospital outcomes among patients with heart failure, the in-hospital outcomes for patients undergoing durable Left Ventricular Assist Device (LVAD) implantation or Heart Transplantation (HT) based on SES have not been well characterized. We analyzed data from the National Inpatient Sample of hospitalizations between January 2016 and December 2020 of patients aged 18 and over who underwent a HT or newly implanted LVAD. Quartile classification of the median household income of the patient's residential zip code was used to estimate SES. Multivariable analyses with logistic and linear regression were used to evaluate the effects of SES on inpatient outcomes including inpatient mortality, length of stay, and key inpatient complications. A total of 16,265 weighted hospitalizations for new LVAD implantation and 14,320 weighted hospitalizations for HT were identified. In multivariable analysis, among patients undergoing HT or LVAD implantation respectively, there were no significant differences between the lowest and highest SES quartiles among important in-hospital outcomes including length of stay (adj B-coeff .56, (-3.59)-(4.71), p = .79 and adj B-coeff 2.40, (-.21)-(5.02), p = .07) and mortality (aOR 1.02, .61-1.70, p = .94 and aOR 1.08, .72-1.62, p = .73). There were also no differences based on SES quartile in important inpatient complications including stroke and cardiac arrest. In this analysis from the National Inpatient Sample, we demonstrate that SES, evaluated by median zip code income, was not associated with important in-hospital metrics including mortality and length of stay among patients undergoing LVAD or HT.

Identifiants

pubmed: 37548056
doi: 10.1111/ctr.15093
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15093

Informations de copyright

© 2023 The Authors. Clinical Transplantation published by John Wiley & Sons Ltd.

Références

Abramov D, Minhas AMK, Fudim M, Chung JS, Patel JN, Rabkin DG. Impact of the heart transplant allocation policy change on inpatient cost of index hospitalization. Clin Transplant. 2022;36:e14692.
Sanaiha Y, Downey P, Lyons R, Nsair A, Shemin RJ, Benharash P. Trends in utilization, mortality, and resource use after implantation of left ventricular assist devices in the United States. J Thorac Cardiovasc Surg. 2021;161:2083-2091.
https://hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2020.jsp
Averbuch T, Mohamed M, Islam S, et al. The association between socioeconomic status, sex, race/ethnicity and in-hospital mortality among patients hospitalized for heart failure. J Card Fail. 2022;28:697-709.
https://hcup-us.ahrq.gov/db/vars/zipinc_qrtl/nisnote.jsp
Clerkin KJ, Garan AR, Wayda B, et al. Impact of socioeconomic status on patients supported with a left ventricular assist device: an analysis of the UNOS database (United Network for Organ Sharing). Circ Heart Fail. 2016;9:e003215.
Clemons AM, Flores RJ, Blum R, et al. Effect of socioeconomic status on patients supported with contemporary left ventricular assist devices. ASAIO J. 2020;66:373-380.
Han JJ, Iyengar A, Fowler C, et al. Impact of socioeconomic status on outcomes after ventricular assist device implantation using the area deprivation index. J Card Fail. 2021;27:597-601.
Ibarra A, Howard-Quijano K, Hickey G, et al. The impact of socioeconomic status in patients with left ventricular assist devices (LVADs). J Card Surg. 2021;36:3501-3508.
Hawkins NM, Jhund PS, McMurray JJ, Capewell S. Heart failure and socioeconomic status: accumulating evidence of inequality. Eur J Heart Fail. 2012;14:138-146.
Kwok CS, Abramov D, Parwani P, et al. Cost of inpatient heart failure care and 30-day readmissions in the United States. Int J Cardiol. 2021;329:115-122.
Rao VN, Mentz RJ, Coniglio AC, et al. Neighborhood socioeconomic disadvantage and hospitalized heart failure outcomes in the American Heart Association get with the guidelines-heart failure registry. Circ Heart Fail. 2022;15:e009353.
DeFilippis EM, Clerkin KJ, Givens RC, et al. Impact of socioeconomic deprivation on evaluation for heart transplantation at an urban academic medical center. Clin Transplant. 2022;36:e14652.
Larsson J, Kristensen SL, Madelaire C, et al. Socioeconomic disparities in referral for invasive hemodynamic evaluation for advanced heart failure: a nationwide cohort study. Circ Heart Fail. 2021;14:e008662.
Tchoukina I, Shah KB, Thibodeau JT, et al. Impact of socioeconomic factors on patient desire for early LVAD therapy prior to inotrope dependence. J Card Fail. 2020;26:316-323.

Auteurs

Abdul Mannan Khan Minhas (AMK)

Division of Medicine, Forrest General Hospital, Hattiesburg, Mississippi, USA.

Marat Fudim (M)

Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

A Reshad Garan (AR)

Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Jonathan D Davis (JD)

Department of Medicine, Division of Cardiology, University of San Francisco, San Francisco, California, USA.

Gregg C Fonarow (GC)

Department of Medicine, Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Steve M Antoine (SM)

Michael E DeBakey Veterans Affairs Hospital and Baylor College of Medicine, Center for Cardiovascular Disease Prevention, Houston, Texas, USA.

Savitri Fedson (S)

Michael E DeBakey Veterans Affairs Hospital and Baylor College of Medicine, Center for Cardiovascular Disease Prevention, Houston, Texas, USA.

Vijay Nambi (V)

Michael E DeBakey Veterans Affairs Hospital and Baylor College of Medicine, Center for Cardiovascular Disease Prevention, Houston, Texas, USA.

Dmitry Abramov (D)

Department of Medicine, Division of Cardiology, Loma Linda Medical Center, Loma Linda, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH